FDA Inspection
Fresenius Kabi Compounding, LLCFresenius Kabi Compounding, LLC – FDA Inspection, Dec 4, 2018
Record Details
This FDA Inspection record concerns Fresenius Kabi Compounding, LLC, with an inspection on December 4, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · ce034b7f-9876-47d3-84c4-a4cd15a8b819
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1074214
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
11- 21 CFR 211.42(c)(10)(v)Cleaning System
- 21 CFR 211.42(c)(10)(iv)Environmental Monitoring System
- 21 CFR 211.94(b)Protection from external factors
- 21 CFR 211.160(a)Following/documenting laboratory controls
- 21 CFR 211.160(b)Scientifically sound laboratory controls
- 21 CFR 211.113(b)Procedures for sterile drug products
- 21 CFR 211.113(b)Validation lacking for sterile drug products
- 21 CFR 211.165(a)Testing and release for distribution
- FDCA 503B(a)(10)Drug product label, outsourcer facility
- 21 CFR 211.192Investigations of discrepancies, failures
Showing 10 of 11 citations.
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Fresenius Kabi Compounding, LLC
2| Date | Classification | Office | Project area |
|---|---|---|---|
| November 5, 2025 | Not classified | New England District Office | Drug Quality Assurance |
| March 6, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Fresenius Kabi Compounding, LLC
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.